製藥無菌填充與包裝市場：現況分析與預測（2023-2030）

Pharmaceutical Sterile Fill-Finish Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年03月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 123 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

無菌填充和精加工製程在製藥業中發揮最重要的作用，特別是在註射劑、疫苗和各種其他無菌藥品的生產中。這個複雜的過程涉及多個關鍵步驟，旨在確保最終產品不受微生物污染並確保穩定性和治療功效。無菌填充和精加工製程在藥品製造中至關重要，特別是在註射劑、疫苗和生物製劑的製造中，保持無菌至關重要。這個過程涉及一系列步驟，例如填充、加塞、加蓋，有時還需要冷凍乾燥，以生產最終劑型。市場驅動因素之一是慢性病的增加和生物製品的發展。例如，疾病管制與預防中心的數據顯示，60% 的美國人患有至少一種慢性疾病，例如心臟病、糖尿病或癌症。

2022 年，製藥無菌填充和加工市場估值為 35 億美元，預計 2023 年至 2030 年複合年增長率約為 5%。

產品分為西林瓶、預充式註射器、藥筒等。近年來，小瓶領域的需求不斷增加。由於西林瓶具有多功能性、與多種藥物的兼容性以及更高的安全性，長期以來一直是製藥業無菌填充過程的選擇。

依應用，市場分為疫苗、生物製劑、生物相似藥等。其中，生物相似藥類別預計將以最高的複合年增長率成長。由於對創新治療的需求不斷增加以及一些重磅生物製劑的專利到期，生物相似藥正在經歷顯著增長。

為了更瞭解產業市場採用情況，市場包括北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、義大利、西班牙、歐洲其他地區）、亞太地區（中國、日本）、印度、韓國、澳洲和亞太地區其他地區）以及世界其他地區。到 2022 年，北美將在製藥無菌填充和加工市場中佔壓倒性佔有率。北美擁有完善的醫療基礎設施，不斷上漲的醫療成本和不斷增加的慢性病患者數量是推動北美市場成長的主要因素。

市場上營運的主要公司包括 Baxter Biopharma Solutions Boehringer Ingelheim、Vetter Pharma、Fresenius Kabi、Pfizer CenterOne、Aenova、Wuxi Biologics、Jubilant Hollister，其中包括 Steer、Bushu Pharmaceutical 和 LSNE Contract Manufacturing。

北美製藥無菌填充與加工市場
- 美國
- 加拿大
- 其他北美地區
歐洲製藥無菌填充加工市場
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲地區
亞太製藥無菌填充與加工市場
- 中國
- 日本
- 印度
- 亞太地區其他國家
其他地區藥品無菌填充加工市場

第10章製藥無菌填充與整理市場動態

市場驅動因素
市場課題
影響分析

第 11 章製藥無菌填充與精加工市場機會

第 12 章藥品無菌填充與加工市場趨勢

第十三章供需分析

需求方分析
供給面分析

第14章價值鏈分析

第15章比賽場景

競爭狀況
- 波特五力分析

第十六章公司簡介

Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing

第十七章免責聲明

簡介目錄

Product Code: UMHE212670

The sterile fill-finish procedure holds paramount importance within the pharmaceutical sector, particularly concerning the manufacturing of injectable medications, vaccines, and various other sterile pharmaceuticals. This intricate process encompasses multiple pivotal stages aimed at guaranteeing the absence of microbial contamination in the final product, while also safeguarding its stability and therapeutic effectiveness. The sterile fill-finish process is a critical step in pharmaceutical manufacturing, especially for injectable drugs, vaccines, and biologics where maintaining sterility is paramount. It involves a series of steps including filling, stoppering, capping, and sometimes lyophilization (freeze-drying) to produce the final dosage form. One of the major driver for the growth of the market is associated with the increasing prevalence of chronic diseases and the development of biologic drugs. For instance, as per the data of Certers for Disease Control and Prevention, 60% of the Amaercans are living with atleast one of the chronic disorder like heart disease, diabetes, or cancer.

The Pharmaceutical Sterile Fill-Finish Market was valued at USD 3,500 Million in 2022 and is expected to grow at a CAGR of around 5% from 2023-2030.

Based on the product, the market is segmented into Vials, Prefilled Syringes, Cartridges, and Others. Vials segment have been experiencing an increasing demand in recent years. Vials have long been a preferred choice in the pharmaceutical industry for sterile fill-finish processes due to their versatility, compatibility with a wide range of drugs, and enhanced safety features.

On the basis of application, the market is categorized into Vaccine, Biologics, Biosimilars, and Others. Among these, the Biosimilar category is expected to grow with the highest CAGR. Biosimilars were experiencing significant growth due to increased demand for innovative therapies and the expiration of patents on several blockbuster biologic drugs.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Pharmaceutical Sterile Fill-Finish Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure and rising cases of chronic disorders in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include Baxter BioPharma Solutions Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier, Bushu Pharmaceuticals, LSNE Contract Manufacturing

1.MARKET INTRODUCTION

1.1.Market Definitions
1.2.Main Objective
1.3.Stakeholders
1.4.Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

2.1.Research Process of the Pharmaceutical Sterile Fill-Finish Market
2.2.Research Methodology of the Pharmaceutical Sterile Fill-Finish Market
2.3.Respondent Profile

3.MARKET SYNOPSIS

4.EXECUTIVE SUMMARY

5.GLOBAL PHARMACEUTICAL STERILE FILL-FINISH MARKET COVID-19 IMPACT

6.GLOBAL PHARMACEUTICAL STERILE FILL-FINISH MARKET REVENUE, 2020-2030F

7.MARKET INSIGHTS BY PRODUCT

7.1.Vials
7.2.Prefilled Syringes
7.3.Cartridges
7.4.Others

8.MARKET INSIGHTS BY APPLICATION

8.1.Vaccines
8.2.Biologics
8.3.Biosimilars
8.4.Others

9.MARKET INSIGHTS BY REGION

9.1.North America Pharmaceutical Sterile Fill-Finish Market
- 9.1.1.U.S.
- 9.1.2.Canada
- 9.1.3.Rest of North America
9.2.Europe Pharmaceutical Sterile Fill-Finish Market
- 9.2.1.Germany
- 9.2.2.UK
- 9.2.3.France
- 9.2.4.Italy
- 9.2.5.Spain
- 9.2.6.Rest of Europe
9.3.Asia-Pacific Pharmaceutical Sterile Fill-Finish Market
- 9.3.1.China
- 9.3.2.Japan
- 9.3.3.India
- 9.3.4.Rest of APAC
9.4.Rest of the World Pharmaceutical Sterile Fill-Finish Market